NCT05926817 is a NA clinical trial of QTC-VR headsets in Virtual Reality, sponsored by Tianjin Medical University.

Who is sponsoring NCT05926817?

NCT05926817 is sponsored by Tianjin Medical University.

What drugs are being tested in NCT05926817?

Interventions in NCT05926817: Placebo-VR headsets, QTC-VR headsets.

What condition does NCT05926817 study?

NCT05926817 studies Virtual Reality, Acute Postoperative Pain, Thoracic Surgery, Video-Assisted.

Is NCT05926817 still recruiting?

NCT05926817 is currently completed. Last updated 5 February 2024.

Last reviewed 2024-02-05 · How we verify

NCT05926817

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Virtual Reality on Patients With Acute Pain After Thoracoscopic Surgery

Completed NA Last updated 5 February 2024

What this trial tests

NA trial testing Placebo-VR headsets in Virtual Reality in 61 participants. Completed in 7 March 2023.

Timeline

19 October 2021

Primary endpoint
6 March 2023

7 March 2023

Quick facts

Lead sponsor	Tianjin Medical University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	61
Start date	19 October 2021
Primary completion	6 March 2023
Estimated completion	7 March 2023
Sites	1 location across China

Drugs / interventions tested

Placebo-VR headsets
QTC-VR headsets

Conditions studied

Virtual Reality — all drugs for Virtual Reality →
Acute Postoperative Pain — all drugs for Acute Postoperative Pain →
Thoracic Surgery, Video-Assisted — all drugs for Thoracic Surgery, Video-Assisted →

Sponsor

Tianjin Medical University

Who can join

18 and older, any sex, with Virtual Reality or Acute Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Immersive virtual reality (VR) as a non-pharmaceutical technology may deliver effective behavioral therapies for postsurgical patients with acute pain. To determine the analgesic effects of VR on patients after thoracoscopic surgery. The investigators conducted a randomized clinical trial to determine the postoperative effect of VR on pain relief in patients undergoing thoracoscopic surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of virtual reality intervention on hospitalized patients with acute pain after thoracoscopic surgery: a pilot randomized clinical trial.
Cao W, Ren F, Li T, Ma F, et al · · 2025 · PMID 39878180 · DOI 10.1097/js9.0000000000002264

Verify or expand the search:

Other recruiting trials for Virtual Reality

Currently open trials in the same condition.

NCT07387107 — Decreasing Stress Via Virtual Reality and Binaural Beats in Non-Clinical Adults · NA · recruiting
NCT07343843 — Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes Duri · NA · recruiting
NCT07410858 — Virtual Reality-Enhanced Parent Education in Neonatal Intensive Care · NA · recruiting
NCT07021638 — EMMVIES : Walking Training at Home in VIrtual Reality for Children With Chronic Illnesses Impacting Physical Health · NA · recruiting
NCT07236229 — The Effects of Immersive Virtual Reality in Patients With Grade 1-2 Adhesive Capsulitis · NA · recruiting

Other Tianjin Medical University trials

Trials by the same sponsor.

NCT07393685 — Effectiveness of Xuanfei Jiangzhuo Decoction for Influenza-Induced AECOPD · not yet recruiting
NCT07306598 — [18F]NIDF PET Imaging in Tau-related Diseases · recruiting
NCT07232459 — [18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis · recruiting
NCT06949670 — Alpha-Synuclein PET/CT in Various α-Syn-Related Disease · recruiting
NCT06628531 — ALI & Pulmonary HA Deposition After SAH · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05926817 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tianjin Medical University
Last refreshed: 5 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05926817.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing